Unique ID issued by UMIN | UMIN000034130 |
---|---|
Receipt number | R000038910 |
Scientific Title | Efficacy trial of repeated intake of plant derived ingredient. [trial number g2018007] |
Date of disclosure of the study information | 2018/09/25 |
Last modified on | 2018/09/14 08:44:53 |
Efficacy trial of repeated intake of plant derived ingredient. [trial number g2018007]
Efficacy of plant derived ingredient. [trial number g2018007]
Efficacy trial of repeated intake of plant derived ingredient. [trial number g2018007]
Efficacy of plant derived ingredient. [trial number g2018007]
Japan |
Healthy adults
Not applicable | Adult |
Others
NO
To investigate effects of repeated consumption of a plant derived ingredient for 2 weeks on glucose metabolism in healthy adults with high normal and impaired fasting glucose
Efficacy
Blood glucose
Insulin, glucagon, 1.5-AG, glycol-albumin, gastrointestinal hormone, triglyceride, apo B48, ketone body, body weight, body fat ratio, appetite (questionnaire)
Interventional
Cross-over
Randomized
Individual
Double blind -all involved are blinded
Placebo
YES
NO
YES
No need to know
2
Treatment
Food |
Repeated intake control food, once in a day for 2 weeks, after wash out for 2 weeks, repeated intake test food, once in a day for 2 weeks.
Repeated intake test food, once in a day for 2 weeks, after wash out for 2 weeks, repeated intake control food, once in a day for 2 weeks.
20 | years-old | <= |
64 | years-old | >= |
Male
(1) Healthy male adults aged from 20 y to 64 y
(2) Subjects with fasting glucose from 100 to 125 mg/dl
(3) Subjects can consume test foods, and record life diaries and meal diaries
(4) Subjects who have given written informed consent prior to study
(1) Subjects diagnosed with diabetes, or taking drugs related diabetes
(2) Subjects who have history or symptom of cardiovascular disease or cerebrovascular disease
(3) Subjects who have symptom of liver, kidney or respiratory disease, endocrine disorder, metabolic disorder, organ disorder, gout, rheumatism, autoimmune disease, allergy disease, mental disorder, cancer, infection disease, or other diseases
(4) Subjects who have a history of resection of gastrointestinal tract, excluding cecal resection surgery
(5) Heavy drinker (over 30g alcohol per day)
(6) Subjects who have donated over 200 ml of blood within the last one month prior to the current study or over 400 ml of blood within the last three months prior to the study
(7) Subjects who have severe anemia (Hb <=7g/dL)
(8) Subjects who have food allergies for test foods
(9) Subjects who are planned to participate in other clinical study during current study
(10) Subjects who are judged to be inappropriate for the study by the medical doctor or principal investigator for other reason
14
1st name | |
Middle name | |
Last name | Masanobu Hibi |
Kao Corporation
Biological Science Research laboratories
2-1-3, Bunka, Sumida-ku, Tokyo, 131-8501, Japan
+81-3-5630-7266
hibi.masanobu@kao.com
1st name | |
Middle name | |
Last name | Ryoma Shimizu |
TES Holdings Co., Ltd.
Administrative Department of Clinical Trials
6F Kairaku Building 2-7-5 Higashiueno Taito-ku Tokyo 110-0015, JAPAN
+81-3-6801-8480
r.shimizu@tes-h.co.jp
TES Holdings Co., Ltd.
Kao Corporation
Profit organization
NO
うえのあさがおクリニック(東京都)
2018 | Year | 09 | Month | 25 | Day |
Unpublished
Preinitiation
2018 | Year | 08 | Month | 31 | Day |
2018 | Year | 09 | Month | 29 | Day |
2018 | Year | 09 | Month | 14 | Day |
2018 | Year | 09 | Month | 14 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038910